High pressure homogenization of pharmaceutical solids

被引:47
作者
Kluge, Johannes [1 ]
Muhrer, Gerhard [2 ]
Mazzotti, Marco [1 ]
机构
[1] Swiss Fed Inst Technol, Inst Proc Engn, CH-8092 Zurich, Switzerland
[2] Novartis Pharma AG, CH-4056 Basel, Switzerland
关键词
Homogenization; Pharmaceutical; Microparticles; Comminution; High pressure; Carbon dioxide; POORLY SOLUBLE DRUGS; MICRONIZATION; NANOCRYSTALS; INGREDIENTS; DISSOLUTION; FORMULATION; TECHNOLOGY; PARTICLES; DELIVERY;
D O I
10.1016/j.supflu.2012.01.009
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The comminution of different pharmaceutical solids by high pressure homogenization in various dispersion media has been investigated. First, the influence of two important process parameters, namely the pressure drop and the number of passes across the homogenizer, has been investigated through the homogenization of aqueous suspensions. Applying pressure drops ranging from 250 to 1000 bar and up to 200 passes across the homogenizer, it was found that smaller particles can be obtained either by working at an increased homogenization pressure or by further increasing the number of passes. The smallest particles, obtained for one of the two pharmaceutical compounds investigated by applying 50 passes at 1000 bar homogenization pressure, exhibited a very narrow size distribution with a median x(50) of 1.14 mu m. Moreover, experimental results could be adequately described using an empirical relationship that allows estimating a priori the median x(50) of the product size distribution as a function of the aforementioned operating parameters. Furthermore, the performance of different homogenizers has been evaluated, thus showing that valve homogenizers have favorable properties as compared to static homogenizers regarding the comminution of solids. Finally, the present study demonstrates successfully the feasibility of this novel process option by applying two different pressurized dispersion fluids, namely liquid carbon dioxide or 1,1,1,2-tetrafluoroethane (Solkane R134a), in the homogenization of phenytoin and of another proprietary pharmaceutical solid. These fluids are subject to residue-free evaporation upon pressure release, and at the end of the process the micronized product particles could be directly recovered in form of a dry powder. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:380 / 388
页数:9
相关论文
共 20 条
[1]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]   Nanomedicines for ocular NSAIDs: safety on drug delivery [J].
Araujo, Joana ;
Gonzalez, Elisabet ;
Egea, Maria Antonia ;
Garcia, Marisa Luisa ;
Souto, Eliana B. .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2009, 5 (04) :394-401
[3]   Nanoparticles synthesis using supercritical fluid technology - towards biomedical applications [J].
Byrappa, K. ;
Ohara, S. ;
Adschiri, T. .
ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (03) :299-327
[4]   High-pressure homogenization as a non-thermal technique for the inactivation of microorganisms [J].
Diels, Ann M. J. ;
Michiels, Chris W. .
CRITICAL REVIEWS IN MICROBIOLOGY, 2006, 32 (04) :201-216
[5]   CONTEMPORARY APPROACHES IN AEROSOLIZED DRUG DELIVERY TO THE LUNG [J].
GUPTA, PK ;
HICKEY, AJ .
JOURNAL OF CONTROLLED RELEASE, 1991, 17 (02) :127-147
[6]   BACTERIAL-CELL DISRUPTION - A KEY UNIT OPERATION IN THE RECOVERY OF INTRACELLULAR PRODUCTS [J].
HARRISON, STL .
BIOTECHNOLOGY ADVANCES, 1991, 9 (02) :217-240
[7]   Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation [J].
Keck, CM ;
Müller, RH .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 62 (01) :3-16
[8]   Application of a multi-pass high-pressure homogenization treatment for the pasteurization of fruit juices [J].
Maresca, Paola ;
Donsi, Francesco ;
Ferrari, Giovanna .
JOURNAL OF FOOD ENGINEERING, 2011, 104 (03) :364-372
[9]   Edible nanoemulsions: fabrication, properties, and functional performance [J].
McClements, David Julian .
SOFT MATTER, 2011, 7 (06) :2297-2316
[10]  
Muhrer G., 2005, International Patent, Patent No. [WO2005089718-A2, 2005089718]